Prudential Financial
AVIR icon

Prudential Financial’s Atea Pharmaceuticals AVIR Stock Holding History

Prudential Financial’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.6K Buy
12,180
+780
+7% +$3.88K ﹤0.01% 2409
2026
Q1 		$61.3K Buy
+11,400
New +$52.4K ﹤0.01% 2286
2025
Q4 		– Sell
-10,135
Closed -$29.4K – 2231
2025
Q3 		$29.4K Hold
10,135
– – ﹤0.01% 2388
2025
Q2 		$36.5K Buy
+10,135
New +$30.2K ﹤0.01% 2363
2024
Q1 		– Sell
-110,105
Closed -$336K – 2674
2023
Q4 		$336K Sell
110,105
-3,900
-3% -$11.8K ﹤0.01% 2278
2023
Q3 		$342K Sell
114,005
-101,900
-47% -$347K ﹤0.01% 2211
2023
Q2 		$807K Sell
215,905
-23,500
-10% -$88K ﹤0.01% 1917
2023
Q1 		$802K Sell
239,405
-36,300
-13% -$147K ﹤0.01% 1852
2022
Q4 		$1.33M Sell
275,705
-18,930
-6% -$95.8K ﹤0.01% 1553
2022
Q3 		$1.68M Sell
294,635
-84,700
-22% -$648K ﹤0.01% 1436
2022
Q2 		$2.69M Sell
379,335
-67,780
-15% -$463K ﹤0.01% 1227
2022
Q1 		$3.23M Buy
447,115
+64,600
+17% +$439K ﹤0.01% 1231
2021
Q4 		$3.42M Buy
+382,515
New +$5.96M ﹤0.01% 1248
2021
Q3 		– Sell
-66,875
Closed -$1.44M – 2587
2021
Q2 		$1.44M Sell
66,875
-3,560
-5% -$107K ﹤0.01% 1650
2021
Q1 		$4.35M Buy
+70,435
New +$4.76M 0.01% 1086

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Prudential Financial's AVIR Position: Q2 2026 in Review

Prudential Financial increased its Atea Pharmaceuticals (AVIR) stake by 6.8% in Q2 2026, buying an estimated $3.88K and bringing the position to 12,180 shares worth $56.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Prudential Financial first reported a position in AVIR in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.35M in Q1 2021. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Prudential Financial held 12,180 shares of Atea Pharmaceuticals worth $56.6K as of Q2 2026.
  • Prudential Financial bought 780 Atea Pharmaceuticals shares in Q2 2026, an estimated $3.88K.
  • Atea Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2409 holding.
  • Prudential Financial first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
  • Prudential Financial's Atea Pharmaceuticals position peaked at $4.35M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.